Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Thrombosis and Haemostasis|September 4, 2008
Clinical implications of aspirin resistanceNorbert Zimmermann, Thomas Hohlfeld
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 2, 2008
Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agentNorbert Zimmermann, Emmeran Gams, Thomas Hohlfeld
Herz|June 27, 2008
Aspirin "resistance"Norbert Zimmermann, Artur-Aron Weber, Thomas Hohlfeld
Phytochemistry|September 19, 2003
Formation of novel flavonoids in apple (Malusxdomestica) treated with the 2-oxoglutarate-dependent dioxygenase inhibitor prohexadione-CaSusanne Roemmelt, Norbert Zimmermann, Wilhelm Rademacher, et al.
Clinical Hemorheology and Microcirculation|January 5, 2012
Alterations of serum erythropoietin and thrombopoietin levels in patients undergoing Coronary Artery Bypass Grafting (CABG)Folker Wenzel, Thorben Gettmann, Norbert Zimmermann, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 24, 2005
Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?Norbert Zimmermann, Muhammed Kurt, Angela Wenk, et al.
British Journal of Haematology|April 26, 2002
Flow cytometry analysis of platelet cyclooxygenase-2 expression: induction of platelet cyclooxygenase-2 in patients undergoing coronary artery bypass graftingArtur-Aron Weber, Boris Przytulski, Marc Schumacher, et al.
Platelets|October 25, 2007
Aspirin-induced platelet inhibition in patients undergoing cardiac surgeryNorbert Zimmermann, Muhammed Kurt, Joachim Winter, et al.
Platelets|August 3, 2011
Determination of thromboxane formation, soluble CD40L release and thrombopoietin clearance in apheresis platelet concentratesFolker Wenzel, Anja Baertl, Thomas Hohlfeld, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Design and synthesis of novel potent and selective integrin alphanubeta3 antagonists--novel synthetic routes to isoquinolinone, benzoxazinone, and quinazolinone acetatesWerner Seitz, Hervé Geneste, Gisela Backfisch, et al.
Pageof 2